Contrarian Corpus
Phrase library

Callouts & quotes from 26,677+ activist slides

Every emphasised callout and every pulled quote, extracted slide-by-slide. Search by keyword, filter by slide type or by source.

Showing 19201–19260 of 26,677
callout villain critique

"As a best practice, we believe that UEC should have made a similar disclosure in its SEC filings."

Uranium Energy Corp · UEC Spruce Point Capital · p. 14
callout demand list

"The goal of a Special Meeting will be to replace members of the Board, including CEO Tom Schmitt."

callout other

"ASMLはサイマーの極端紫外線の光源を獲得するために、同社を40億ドルで買収した。サイマーは、極端紫外線光源の実用化に向けた開発は、自社の能力を上回る大規模で広範囲の投資を必要とすると判断した。"

Lasertec Corporation · 6920 Scorpion Capital · p. 170
callout section divider

"AlloSure faces significant competition in the near term and almost certain obsolescence over time"

CareDx, Inc. · CDNA Kerrisdale Capital · p. 23
callout ceo quote

"Our Board nominees would hold SBM to a higher standard and demand better oversight and execution."

GCP Applied Technologies · GCP Starboard Value · p. 11
callout ceo quote

"Management has either forgotten about its prior written statements or is misleading shareholders."

Darden Restaurants, Inc. · DRI Starboard Value · p. 76
callout villain critique

"In 2019 he held two separate signing ceremonies for the contract between New Pacific and COMIBOL."

New Pacific Metals · NUAG Hindenburg Research · p. 15
callout ceo quote

"Shouldn't BlackRock Lead Independent Director be available to meet with a dissenting shareholder?"

BlackRock · BLK Bluebell Capital · p. 36
callout ceo quote

"Spruce Point believes Stryker is wildly overpaying for Vocera at a $3.1 billion dollar valuation."

Stryker Corp. · SYK Spruce Point Capital · p. 95
callout executive summary

"We believe investors are being misguided by Magnite’s growth prospects, and see 25%-50% downside."

Magnite, Inc. · MGNI Spruce Point Capital · p. 5
callout peer gap

"Continued revenue growth decline, notably in Q4 which has historically been the strongest quarter"

Magnite, Inc. · MGNI Spruce Point Capital · p. 29
callout appendix data

"This is clear, straightforward and unambiguous. The words “strict accordance” mean what they say."

BP plc · BP Bluebell Capital · p. 28
callout villain critique

"Evidence indicates that this intermediary was likely a straw buyer controlled by a Company proxy."

KE Holdings · BEKE Muddy Waters · p. 43
callout other

"APP appears to have instead actively retargeted and / or jumped the last click attribution claim."

AppLovin · APP Muddy Waters · p. 7
callout other

"In most cases, these collected identifiers are persistent, with durations up to one or two years."

AppLovin · APP Muddy Waters · p. 20
callout section divider

"We Believe PGNY’s Differentiation Fades As Its Competitive Landscape Becomes Increasingly Crowded"

Progyny, Inc. · PGNY Spruce Point Capital · p. 51
callout other

"ACMR has a massive balance sheet asset that begins converting into revenue a year after shipment."

ACM Research, Inc. · ACMR Kerrisdale Capital · p. 20
callout section divider

"Insiders Are Primed To Sell: We Estimate 55% - 80% Downside Risk Potential To Bunge's Share Price"

Bunge Global SA · BG Spruce Point Capital · p. 62
callout peer gap

"Given its size and scale, TIP REIT will be a “must own” stock for any real estate equity investor"

Target Corporation · TGT Pershing Square · p. 87
callout villain critique

"The definition of insanity is doing the same thing over and over and expecting different results!"

Huntsman Corporation · HUN Starboard Value · p. 13
callout section divider

"We Believe REZI’s $2.0bn+ Spent On Acquisitions Are Troubled And Mask Underlying Financial Issues"

Resideo Technologies, Inc. · REZI Spruce Point Capital · p. 43
callout other

"Fannie and Freddie remain valuable perpetual options on their potential exit from conservatorship"

Pershing Square Holdings · PSH Pershing Square · p. 51
callout villain critique

"Perhaps the only thing more far-fetched than Astra's launch rate is how it expects to hold price."

Astra Space, Inc. · ASTR Kerrisdale Capital · p. 10
callout villain critique

"Fermenters and liquid handling machines are from the same suppliers everyone in the industry uses"

Ginkgo Bioworks · DNA Scorpion Capital · p. 139
callout ceo quote

"For Q4'19 Cintas explicitly guided to no repurchases, yet conducted its biggest buyback in Q4'19."

Cintas Corp. · CTAS Spruce Point Capital · p. 49
callout ceo quote

"athena slipped an accounting change into its third quarter 10Q to accelerate revenue recognition."

AerCap Holdings · AER Greenlight Capital · p. 69
callout villain critique

"Represents over $20 billion of lost value while the Company received a $40 billion+ COVID benefit"

Pfizer Inc. · PFE Starboard Value · p. 8
callout preempt rebuttal

"Elliott is not alone in our recognition of Juniper's share price and operational underperformance"

Juniper Networks · JNPR Elliott Management · p. 8
callout ceo quote

"The SENZA-RCT pivotal trial is the foundation upon which Nevro's high frequency gimmick is built."

Nevro Corp. · NVRO Scorpion Capital · p. 56
callout villain critique

"Comments from one KOL after another were consistent and devastating in their assessment of Omnia."

Nevro Corp. · NVRO Scorpion Capital · p. 135
callout villain critique

"Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro's sales"

Nevro Corp. · NVRO Scorpion Capital · p. 226
callout villain critique

"Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro's sales"

Nevro Corp. · NVRO Scorpion Capital · p. 227
callout villain critique

"We believe investors should adjust downward Ströer's reported EBITDA as shown in the table below."

Ströer SE & Co. KGaA · SAX Muddy Waters · p. 11
callout appendix data

"When Apple pays out 100% of its future cash flow, it depletes its domestic cash sometime in 2014."

Apple Inc. · AAPL Greenlight Capital · p. 24
callout peer gap

"G&A spend remains astronomically high and represents a severe level of cash burn for shareholders"

Capricorn Energy · CNE Palliser Capital · p. 20
callout sop buildup

"Track record of turning around underperforming company-operated restaurants and improving margins"

Wendy's International · WEN Pershing Square · p. 24
callout peer gap

"Disney’s Media business ("Entertainment" and "Sports") significantly under-earns its media peers."

The Walt Disney Company · DIS Trian Partners · p. 10
callout peer gap

"Disney’s Media business (“Entertainment” and “Sports”) significantly under-earns its media peers."

The Walt Disney Company · DIS Trian Partners · p. 39
callout other

"Limbach also used to reference its key secondary markets but ceased disclosing this in late 2022."

Limbach Holdings, Inc. · LMB Spruce Point Capital · p. 51
callout villain critique

"We are highly confident that at least 73.2% of the 54,065 users in the analyzed classes are bots."

GSX Techedu Inc. · GSX Muddy Waters · p. 3
callout sop buildup

"The valuation discount is significant when compared to soft synergies of joint research and sales"

The Timken Company · TKR Relational Investors · p. 11
callout preempt rebuttal

"We believe the Sandell Plan strengthens the ability of FirstGroup to meet its pension obligations"

FirstGroup plc · FGP Sandell · p. 45
callout timeline

"LOW's share price including dividends increased 36% in 2020 and increased 9% year-to-date in 2021"

Pershing Square Holdings · PSH Pershing Square · p. 39
callout villain critique

"Management does not explain this $13.1m of Adj. EBITDA discrepancy used to reap $2.7m of bonuses."

iRobot Corp · IRBT Spruce Point Capital · p. 42
callout villain critique

"This type of systematic disconnect makes it difficult to have a clear debate between the parties."

eBay · EBAY Carl Icahn · p. 1
callout villain critique

"Everything here is a black box - we couldn't even locate the CDER review package, last we looked."

Soleno Therapeutics · SLNO Scorpion Capital · p. 40
callout appendix data

"We are going to wait...we are going to wait...we have not met with their medical science liaison."

Soleno Therapeutics · SLNO Scorpion Capital · p. 395
callout villain critique

"Wary of prescribing Vykat because getting reimbursement approved is so onerous and time-consuming"

Soleno Therapeutics · SLNO Scorpion Capital · p. 406
callout demand list

"What has been the External Directors' assessment of the decline in EVA over the past three years?"

Kao Corporation · 4452 Oasis Management · p. 19
callout villain critique

"Several omissions suggest that the placebo comparison is a contrived attempt to muddy the waters."

Harmony Biosciences Holdings · HRMY Scorpion Capital · p. 113
callout timeline

"CMG’s share price has declined 15% from our average cost at announcement date to January 19, 2018"

Unknown · p. 40
callout peer gap

"We believe Bristol-Myers may have an opportunity to embark upon a similar margin improvement plan"

Bristol-Myers Squibb · BMY Starboard Value · p. 153